Posaconazole‐induced Pseudohyperaldosteronism

Posaconazole‐induced Pseudohyperaldosteronism

Bibliographic Details
Main Authors:	Jutamart Tantiprawan, Sarat Sunthornyothin, Patchaya Boonchaya‐Anant, Thiti Snabboon
Format:	Article
Language:	English
Published:	Wiley 2021-03-01
Series:	Kaohsiung Journal of Medical Sciences
Online Access:	https://doi.org/10.1002/kjm2.12325

Similar Items

Carotid body paraganglioma
by: Suwanna Pitchaiprasert, et al.
Published: (2019-09-01)

Severe Posaconazole-Induced Glucocorticoid Deficiency with Concurrent Pseudohyperaldosteronism: An Unfortunate Two-for-One Special
by: Alejandro Villar-Prados, et al.
Published: (2021-07-01)

Thyrotoxic Hypokalemic Periodic Paralysis Triggered by Dexamethasone Administration
by: Waraporn Polamaung, et al.
Published: (2020-08-01)

Changes in plasma aldosterone level after weight loss by bariatric surgery in morbidly obese patients
by: Preaw Suwannasrisuk, et al.
Published: (2020-04-01)

Changes in Testosterone Levels and Sex Hormone-Binding Globulin Levels in Extremely Obese Men after Bariatric Surgery
by: Patchaya Boonchaya-anant, et al.
Published: (2016-01-01)

Licorice induced pseudohyperaldosteronism, severe hypertension, and long QT
by: Stine Bech Smedegaard, et al.
Published: (2019-12-01)

Licorice: From Pseudohyperaldosteronism to Therapeutic Uses
by: Chiara Sabbadin, et al.
Published: (2019-07-01)

Hypokalemic Periodic Paralysis as the First Manifestation of Thyrotropin-Secreting Pituitary Adenoma
by: Chatchon Kaewkrasaesin, et al.
Published: (2019-01-01)

Posaconazole
by: Bhattacharya M, et al.
Published: (2010-01-01)

Identification of an Alternative Glycyrrhizin Metabolite Causing Liquorice-Induced Pseudohyperaldosteronism and the Development of ELISA System to Detect the Predictive Biomarker
by: Kan'ichiro Ishiuchi, et al.
Published: (2021-05-01)

Mineralocorticoid hypertension and hypokalaemia induced by posaconazole
by: Charlotte Boughton, et al.
Published: (2018-02-01)

Posaconazole for lobomycosis
by: Alessandro C. Pasqualotto, et al.
Published: (2021-03-01)

Posaconazole‐induced hypertension in children with cystic fibrosis
by: Rachael Marpole, et al.
Published: (2021-09-01)

Posaconazole Induced Diffuse Lentigines: A Case Report
by: Kittipoom Chinhiran, et al.
Published: (2018-06-01)

Posaconazole Induced Diffuse Lentigines: A Case Report
by: Kittipoom Chinhiran, M.D., et al.
Published: (2018-03-01)

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.
Published: (2013-01-01)

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.
Published: (2013-02-01)

Role of posaconazole in the treatment of oropharyngeal candidiasis
by: Voichita Ianas, et al.
Published: (2010-06-01)

Posaconazole: An Update of Its Clinical Use
by: Simon Leung, et al.
Published: (2015-10-01)

Comparison of clinical pharmacology of voriconazole and posaconazole
by: Beata M. Sienkiewicz, et al.
Published: (2016-12-01)

Posaconazole-Induced Adrenal Insufficiency in a Case of Chronic Myelomonocytic Leukemia
by: Ann Miller, et al.
Published: (2018-01-01)

Bilateral Carotid Body Paraganglioma
by: Wasita Warachit, et al.
Published: (2021-02-01)

Gynecomastia and hypertension in a patient treated with posaconazole
by: George R. Thompson III, et al.
Published: (2020-12-01)

Posaconazole in the management of refractory invasive fungal infections
by: Stefan Langner, et al.
Published: (2008-09-01)

Posaconazole-Induced Hypertension Masquerading as Congenital Adrenal Hyperplasia in a Child with Cystic Fibrosis
by: Neha Agarwal, et al.
Published: (2020-01-01)

The Impact of Gelatin on the Pharmaceutical Characteristics of Fucoidan Microspheres with Posaconazole
by: Marta Szekalska, et al.
Published: (2021-07-01)

UV Spectrophotometric method for determination of posaconazole: comparison to HPLC
by: Andressa S. Bitencourt, et al.
Published: (2015-10-01)

Primary Adrenal Insufficiency Secondary to Chronic Posaconazole Use
by: Daniela Pirela Araque, MD, et al.
Published: (2020-03-01)

Posaconazole treatment of refractory eumycetoma and chromoblastomycosis Tratamento com posaconazol de casos de cromoblastomicose e micetoma maduromicótico resistentes a outros antifúngicos
by: Ricardo Negroni, et al.
Published: (2005-12-01)

Prolonged Vincristine Toxicity Induced by Concurrent Posaconazole in a Child with T-cell Acute Lymphoblastic Leukemia
by: Samin Alavi, et al.
Published: (2013-06-01)

Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis
by: Martínez-Casanova J, et al.
Published: (2018-03-01)

Hypercalcemic Crisis in a Patient with Post-Surgical Hypoparathyroidism
by: Wannita Tingsarat, et al.
Published: (2019-01-01)

Combination With Tomatidine Improves the Potency of Posaconazole Against Trypanosoma cruzi
by: Marianne Rocha-Hasler, et al.
Published: (2021-03-01)

Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
by: Whitley M. Yi, et al.
Published: (2017-09-01)

Improvement of patient compliance with the use of Posaconazole in a BMT unit
by: C.C. Beukes
Published: (2014-04-01)

Breakthrough invasive fungal infection under the use of posaconazole and voriconazole
by: Sze-Hwei Lee, et al.
Published: (2016-05-01)

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection
by: Sarah Allegra, et al.
Published: (2017-11-01)

Posaconazole: A Review of Drug Interactions with HIV Antiretroviral Agents
by: Mara Poulakos, et al.
Published: (2014-03-01)

Evaluation of the role of itraconazole and posaconazole in viral infection as immunomodulatory drugs
by: Falah Hasan Obayes AL-Khikani
Published: (2021-01-01)

Cannot write session to /tmp/vufind_sessions/sess_ra07el8hrf7593365acme9lgq8